Acceleron Pharma Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Acceleron Pharma Inc. | XLRN - |
Last Trade $96.15 |
$92.50 |
$0.00 | 4.9 million | 7/1/2020 |
JP Morgan, SVB Leerink, Cowen |
Co-Manager(s): |
|
Filing(s): |
For IPO Boutique's "scale of 1 to 5" BUY rating on Acceleron Pharma Inc., and our comprehensive analysis, click "Buy Market Research".
Acceleron Pharma Inc. Quote & Chart - Click for current quote -
XLRN
About Acceleron Pharma Inc. (adapted from Acceleron Pharma Inc. prospectus):
Acceleron is a Cambridge-based, clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "XLRN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved